SE446335B - Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin - Google Patents

Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin

Info

Publication number
SE446335B
SE446335B SE8202023A SE8202023A SE446335B SE 446335 B SE446335 B SE 446335B SE 8202023 A SE8202023 A SE 8202023A SE 8202023 A SE8202023 A SE 8202023A SE 446335 B SE446335 B SE 446335B
Authority
SE
Sweden
Prior art keywords
group
carbon atoms
compound
formula
ppp
Prior art date
Application number
SE8202023A
Other languages
English (en)
Swedish (sv)
Other versions
SE8202023L (sv
Inventor
P A E Carlsson
F L E Arvidsson
U A Hacksell
J S M Hjorth
A M Johansson
P L Lindberg
J L G Nilsson
D Sanchez
K A I Svensson
H V Wikstrom
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Priority to SE8202023A priority Critical patent/SE446335B/sv
Priority to NO831040A priority patent/NO164024C/no
Priority to AU12845/83A priority patent/AU564287B2/en
Priority to IE685/83A priority patent/IE55261B1/en
Priority to DE8383850084T priority patent/DE3381885D1/de
Priority to AT83850084T priority patent/ATE56705T1/de
Priority to EP83850084A priority patent/EP0097628B1/fr
Priority to FI831068A priority patent/FI81088C/fi
Priority to JP58051781A priority patent/JPS58177971A/ja
Priority to GB08308657A priority patent/GB2117771B/en
Priority to CA000424804A priority patent/CA1202307A/fr
Priority to ES521080A priority patent/ES8405372A1/es
Priority to HU831073A priority patent/HU191290B/hu
Priority to DK143483A priority patent/DK162214C/da
Priority to GR70924A priority patent/GR79244B/el
Priority to DD83249351A priority patent/DD209621A5/de
Priority to PT76481A priority patent/PT76481B/pt
Publication of SE8202023L publication Critical patent/SE8202023L/xx
Priority to ES530186A priority patent/ES530186A0/es
Priority to US06/656,616 priority patent/US4719219A/en
Priority to ES539031A priority patent/ES8601889A1/es
Publication of SE446335B publication Critical patent/SE446335B/sv
Priority to US07/126,916 priority patent/US4937346A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
SE8202023A 1979-12-05 1982-03-30 Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin SE446335B (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE8202023A SE446335B (sv) 1982-03-30 1982-03-30 Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin
NO831040A NO164024C (no) 1982-03-30 1983-03-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner.
AU12845/83A AU564287B2 (en) 1982-03-30 1983-03-25 N-propyl,3-(substituted phenyl)piperidine
IE685/83A IE55261B1 (en) 1982-03-30 1983-03-28 Enantiomers of substituted phenylpiperidines
DE8383850084T DE3381885D1 (de) 1982-03-30 1983-03-28 Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
AT83850084T ATE56705T1 (de) 1982-03-30 1983-03-28 Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EP83850084A EP0097628B1 (fr) 1982-03-30 1983-03-28 Dérivés de pipéridine, procédés pour leur préparation et préparations pharmaceutiques les contenant
ES521080A ES8405372A1 (es) 1982-03-30 1983-03-29 Un procedimiento para preparar un enantiomero puro de un fenilazacicloalcano sustituido.
GR70924A GR79244B (fr) 1982-03-30 1983-03-29
GB08308657A GB2117771B (en) 1982-03-30 1983-03-29 Enantiomers of substituted phenylazacycloalkanes
CA000424804A CA1202307A (fr) 1982-03-30 1983-03-29 (-)(hydroxy-3 phenyl)-3-n-n-propylpiperidine et ses derives
FI831068A FI81088C (fi) 1982-03-30 1983-03-29 Foerfarande foer framstaellning av farmakologiskt aktiva, rena enantiomerer av n-n-propyl-3-(3-hydroxifenyl)-piperidinderivater.
HU831073A HU191290B (en) 1982-03-30 1983-03-29 Process for preparing the enantiomers of substituted phenyl-piperidine derivatives
DK143483A DK162214C (da) 1982-03-30 1983-03-29 Analogifremgangsmaade til fremstilling af en ren enantiomer af 3-fenyl-n-n-propylpiperidinderivater
JP58051781A JPS58177971A (ja) 1982-03-30 1983-03-29 置換フエニルアザシクロアルカン化合物およびド−パミンレセプタ−作働剤
DD83249351A DD209621A5 (de) 1982-03-30 1983-03-30 Verfahren zur herstellung von enantiomeren substituierter phenylazacycloalkane
PT76481A PT76481B (en) 1982-03-30 1983-03-30 Process for preparing new enantiomers of substituted phenylazacycloalkanes and of pharmaceutical compositions
ES530186A ES530186A0 (es) 1982-03-30 1984-03-01 Un procedimiento para preparar un enantiomero puro de un fenilazacicloalcano sustituido
US06/656,616 US4719219A (en) 1982-03-30 1984-10-01 Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders
ES539031A ES8601889A1 (es) 1982-03-30 1984-12-24 Un procedimiento para preparar un enantiomero puro de un fenilazacicloalcano sustituido
US07/126,916 US4937346A (en) 1979-12-05 1987-11-30 Phenyl-azacykloalkanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8202023A SE446335B (sv) 1982-03-30 1982-03-30 Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin

Publications (2)

Publication Number Publication Date
SE8202023L SE8202023L (sv) 1983-10-01
SE446335B true SE446335B (sv) 1986-09-01

Family

ID=20346417

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8202023A SE446335B (sv) 1979-12-05 1982-03-30 Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin

Country Status (17)

Country Link
EP (1) EP0097628B1 (fr)
JP (1) JPS58177971A (fr)
AT (1) ATE56705T1 (fr)
AU (1) AU564287B2 (fr)
CA (1) CA1202307A (fr)
DD (1) DD209621A5 (fr)
DE (1) DE3381885D1 (fr)
DK (1) DK162214C (fr)
ES (3) ES8405372A1 (fr)
FI (1) FI81088C (fr)
GB (1) GB2117771B (fr)
GR (1) GR79244B (fr)
HU (1) HU191290B (fr)
IE (1) IE55261B1 (fr)
NO (1) NO164024C (fr)
PT (1) PT76481B (fr)
SE (1) SE446335B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8305362D0 (sv) * 1983-09-30 1983-09-30 Astra Laekemedel Ab Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
JP2011057619A (ja) * 2009-09-10 2011-03-24 Tokai Univ 光学活性アミン化合物の製造方法、並びに、ジアステレオマー塩及びその製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50674B1 (en) * 1979-12-05 1986-06-11 Astra Laekemedel Ab Phenyl-azacycloakanes

Also Published As

Publication number Publication date
DE3381885D1 (de) 1990-10-25
ES521080A0 (es) 1984-06-01
FI81088C (fi) 1990-09-10
GB2117771B (en) 1985-12-04
PT76481A (en) 1983-04-01
GB2117771A (en) 1983-10-19
FI81088B (fi) 1990-05-31
EP0097628B1 (fr) 1990-09-19
FI831068A0 (fi) 1983-03-29
NO831040L (no) 1983-10-03
ES8602655A1 (es) 1985-12-01
IE55261B1 (en) 1990-07-18
EP0097628A2 (fr) 1984-01-04
ES8405372A1 (es) 1984-06-01
SE8202023L (sv) 1983-10-01
HU191290B (en) 1987-02-27
GR79244B (fr) 1984-10-22
NO164024B (no) 1990-05-14
DK162214C (da) 1992-03-16
GB8308657D0 (en) 1983-05-05
DD209621A5 (de) 1984-05-16
DK143483D0 (da) 1983-03-29
ES530186A0 (es) 1985-12-01
JPS6155906B2 (fr) 1986-11-29
IE830685L (en) 1983-09-30
DK162214B (da) 1991-09-30
AU564287B2 (en) 1987-08-06
EP0097628A3 (en) 1984-07-18
NO164024C (no) 1990-08-22
PT76481B (en) 1986-02-27
ES539031A0 (es) 1985-11-16
CA1202307A (fr) 1986-03-25
ATE56705T1 (de) 1990-10-15
JPS58177971A (ja) 1983-10-18
DK143483A (da) 1983-10-01
FI831068L (fi) 1983-10-01
ES8601889A1 (es) 1985-11-16
AU1284583A (en) 1983-10-06

Similar Documents

Publication Publication Date Title
RU2105758C1 (ru) Гидрированные азотсодержащие гетероциклические соединения, производные пиперидина, фармацевтическая композиция и способ подавления активности вещества р в организме
Wikstroem et al. Resolved 3-(3-Hydroxyphenyl)-Nn-propylpiperidine and its analogs: central dopamine receptor activity
EP0975595B9 (fr) Analogues de cocaine
HU213915B (en) Process for producing of n-alkylene piperidino compounds, their enantiomers and pharmaceutical compositions comprising them
HUT61719A (en) Process for producing 2-aminotetraline derivatives and pharmaceutical compositions comprising such compounds
FI82930B (fi) Foerfarande foer framstaellning av farmakologiskt aktiva oktahydrobentso (f) kinolinderivat.
IE42216B1 (en) Benzomorphane derivatives
KR0169497B1 (ko) 신규한 시클로헥실벤즈아미드 유도체, 그의 제조방법 및 약제로서의 용도
FI107607B (fi) Menetelmä terapeuttisesti käyttökelpoisen 1,4-piperidiinijohdannaisen valmistamiseksi
HU196073B (en) Process for production of derivatives of spirodioxolane, spiroditiolane and spirooxa-tiolane and medical compounds containing such compositions
US6440996B1 (en) Monomeric and dimeric heterocycles, and therapeutic uses thereof
EA017631B1 (ru) Кристаллическое основание транс-1-((1r,3s)-3-фенил-6-хлороиндан-1-ил)-3,3-диметилпиперазина
SE446335B (sv) Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin
NZ196086A (en) 1-phenyl-2-cyclohexene-1-alkylamine derivatives and pharmaceutical compositions
US5389638A (en) Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
JPH0377866A (ja) 新規４，４‐二置換ピペリジン誘導体、それらを含む医薬組成物およびそれらの調製方法
US4719219A (en) Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders
EP0034647B1 (fr) Dérivés de 4-aryloxy-3-phényl-pipéridine, produits intermédiaires, procédé pour leur préparation et leur utilisation comme médicaments
US5641785A (en) Oxazoloquinolinone derivatives, their preparation and their therapeutic application as inhibitors of monoamine oxidase
IL90043A (en) Sulfonanilides, their preparation and pharmaceutical preparations containing them
US5118687A (en) 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same
US4937346A (en) Phenyl-azacykloalkanes
AU8455082A (en) Therapeutically useful tetralin derivatives iii,processes forpreparation and pharmaceutical preparations for such compounds
EP1409490B1 (fr) Derives de 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a|naphtalenyle a activite antipsychotique
KR810000093B1 (ko) 치환된 1,3-디하이드로스피로〔이소벤조푸란]류의 제조방법